Chemoinformaics analysis of 3,6-DIMETHYLCOUMARAN
| Molecular Weight | 148.205 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 10 |
| Exact Molecular Weight | 148.089 | nRing | 2 |
| Solubility: LogS | -3.421 | nHRing | 1 |
| Solubility: LogP | 3.331 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 25.5035 |
| nHD | 0 | BPOL | 13.7745 |
| QED | 0.549 |
| Synth | 2.702 |
| Natural Product Likeliness | 1.091 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.075 |
| Pgp-sub | 0.02 |
| HIA | 0.003 |
| CACO-2 | -4.485 |
| MDCK | 0.000024 |
| BBB | 0.584 |
| PPB | 0.948501 |
| VDSS | 1.778 |
| FU | 0.069203 |
| CYP1A2-inh | 0.97 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.839 |
| CYP2c19-sub | 0.87 |
| CYP2c9-inh | 0.287 |
| CYP2c9-sub | 0.734 |
| CYP2d6-inh | 0.582 |
| CYP2d6-sub | 0.922 |
| CYP3a4-inh | 0.146 |
| CYP3a4-sub | 0.599 |
| CL | 11.987 |
| T12 | 0.287 |
| hERG | 0.033 |
| Ames | 0.784 |
| ROA | 0.075 |
| SkinSen | 0.252 |
| Carcinogencity | 0.755 |
| EI | 0.956 |
| Respiratory | 0.426 |
| NR-Aromatase | 0.019 |
| Antiviral | No |
| Prediction | 0.873732 |